Insider filing · AXGN

Amy McBride Wendell sold $1.3M of Axogen (AXGN)

Executed Dec 16 2025, disclosed Dec 17 2025, 1 day later.

Returns are measured on stock purchases only.

AW Amy McBride Wendell Director profile →

Amy McBride Wendell (Director) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Axogen, Inc. (AXGN). Across 1 priced purchase filing, the average 21-session return was -4.5% from execution and -2.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.3M of AXGN (43,684 sh across 3 lots, as filed), executed Dec 16 2025.

AXGN Axogen, Inc. AXGN · Healthcare · 30 filings in 24 months ticker →

Healthcare · Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerv…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→